Jul 2026· International Journal of Drug Delivery Technology· Vol 16· 0 citations· 15 references
TL;DR
Bombax ceiba exhibits excellent acid-neutralizing and cytoprotective effects attributed to phenolics and tannins, whereas Coptis japonica is a potent natural H⁺/K⁺-ATPase inhibitor due to its high alkaloid (berberine) content.
Abstract
Background: Peptic ulcer disease (PUD) remains a global health burden with limitations of current therapies
including side effects of proton pump inhibitors and rising antibiotic resistance against Helicobacter pylori.
Medicinal plants offer multi-targeted gastroprotective alternatives. Objective: To investigate the phytochemical
profile and in-vitro anti-ulcer activity of Bombax ceiba stem bark and Coptis japonica rhizomes. Methods: Aqueous,
hydroalcoholic, methanolic, and ethanolic extracts were prepared. Qualitative and quantitative phytochemical
analyses (total phenolic, flavonoid, alkaloid, and tannin content) were performed. In-vitro anti-ulcer activity was
evaluated using acid-neutralizing capacity (ANC), H⁺/K⁺-ATPase (proton pump) inhibition assay, pepsin inhibition
assay, and cytoprotective activity against ethanol-induced damage in human gastric epithelial (AGS) cells.
Omeprazole and sodium bicarbonate served as standards. Results: Hydroalcoholic extract of B. ceiba showed
highest total phenolic (186.4 mg GAE/g) and flavonoid (112.5 mg QE/g) content, while methanolic extract of C.
japonica exhibited highest alkaloid content (245.8 mg/g). In ANC, B. ceiba hydroalcoholic extract (18.6 mEq/g) was
comparable to sodium bicarbonate (21.2 mEq/g). For H⁺/K⁺-ATPase inhibition, C. japonica methanolic extract (IC₅₀
= 28.4 µg/mL) showed potent activity approaching omeprazole (12.6 µg/mL). Both plants demonstrated
concentration-dependent pepsin inhibition and significant cytoprotection in AGS cells (up to 82% viability at 200
µg/mL). Conclusion: Bombax ceiba exhibits excellent acid-neutralizing and cytoprotective effects attributed to
phenolics and tannins, whereas Coptis japonica is a potent natural H⁺/K⁺-ATPase inhibitor due to its high alkaloid
(berberine) content. Both plants possess multi-target anti-ulcer mechanisms, supporting their traditional use and
offering potential as safer, alternative or adjunctive therapies for peptic ulcer disease.
Background: Peptic ulcer disease remains a major global health concern, with modern lifestyles and widespread NSAID use contributing to its continued prevalence. Medicinal plants have garnered increasing attention as alternative therapeutic approaches due to their antioxidant, anti-inflammatory, and cytoprotective prop...
Abhishek Patel, Garima Pandey, S. S. Chandel· International Journal of Cur...· 0 citations
Background: Inflammation remain significant global health challenges, necessitating the exploration of safer plant-based therapeutic agents. Chamabainia cuspidata, a Himalayan medicinal plant has been traditionally used but lacks comprehensive scientific validation. Objectives: The present study aimed to investigate th...
Panshul Sharma, Nitin Verma· Natural Resources for Human...· 0 citations
MECC exhibited selective cytotoxicity and apoptosis induction in oral cancer cells with minimal toxicity toward normal Vero cells, supporting its potential as a promising natural chemopreventive and an adjunct chemotherapeutic candidate for oral cancer.
M. Khan, Anamika Gupta, A. Srivastava et al.· Tissue & Cell· 0 citations
Insight is given into the use of Persicaria vivipara extract for the treatment of diarrhea by investigating the in vivo and in silico antidiarrheal potential of a methanolic extract of Persicaria vivipara roots.
I. Farzeen, Ayman M. Al-Qaaneh, A. Ishaq et al.· RSC Advances· 0 citations
Kampramong’s ethnobotanical remedies, particularly C. sappan, are promising candidates for URT malignancy treatment and field cancerization prevention, offering valuable data for future drug development.
Nanatphong Paje, A. Itharat, W. Chanvimalueng et al.· International Journal of Mol...· 0 citations
The available literature supports B. orellana as a biologically plausible preclinical mucosal-protective candidate, particularly for prevention of acute chemical injury; however, it does not establish clinical efficacy or chronic ulcer-healing activity.
Asma Syuhaily Mohd Yusof, Y. Keong, L. Fong et al.· Records of Natural Products· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.